Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 31;15(8):1668.
doi: 10.3390/v15081668.

Peripheral Blood and Nasopharyngeal Swab MiRNA-155 Expression in Infants with Respiratory Syncytial Virus Infection

Affiliations

Peripheral Blood and Nasopharyngeal Swab MiRNA-155 Expression in Infants with Respiratory Syncytial Virus Infection

Francesco Savino et al. Viruses. .

Abstract

Introduction: MicroRNA (miR) 155 has been implicated in the regulation of innate and adaptive immunity as well as antiviral responses, but its role during respiratory syncytial virus (RSV) infections is not known. The objective of this study was to investigate the expression of miR-155 using pharyngeal swabs and peripheral blood in infants with RSV infection and uninfected controls.

Methods: A prospective age-matched study was conducted in primary care in Torino from 1 August 2018 to 31 January 2020. We enrolled 66 subjects, 29 of them patients with RSV infection and 37 age-matched uninfected controls, and collected pharyngeal swabs and peripheral blood in order to assess miR-155 expression with real-time stem-loop-TaqMan real-time PCR.

Results: The data show that there is no correlation between pharyngeal swabs and peripheral blood with respect to miR-155 expression. The 1/ΔCq miR-155 expression levels in throat swabs in RSV bronchiolitis patients and healthy controls were 0.19 ± 0.11 and 0.21 ± 0.09, respectively, and were not significantly different between healthy controls and bronchiolitis (p = 0.8414). In the peripheral blood, miR-155 levels were higher than those of healthy control subjects: 0.1 ± 0.013 and 0.09 ± 0.0007, respectively; p = 0.0002.

Discussion: Our data provide evidence that miR-155 expression is higher in peripheral blood during RSV infection but not in swabs. This difference in the timing of sample recruitment could explain the differences obtained in the results; miR-155 activation is probably only assessable in the very early stages of infection in the swab and remains visible for longer in the blood. New investigations are needed in order to clarify whether the miR-155 expression in swabs can be influenced by different stages of virus disease of infants.

Keywords: RSV; antiviral immunity; bronchiolitis; miR-155; miRNA isolation; real-time PCR; swab.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Correlations between transcription levels of mir155 in whole blood and nasopharyngeal swabs: relative quantification. Circles show the mean of three individual measurements. Line: linear regression line. Statistical analysis: Spearman correlation test.
Figure 2
Figure 2
Expression of mir155 in nasopharyngeal swabs and whole blood from 29 patients with RSV-bronchiolitis and 37 healthy controls (HC). 1/DCt: relative quantification. Circles and squares show the median of three individual measurements, horizontal lines the median values. Statistical analysis: the Mann–Whitney test was used to compare the transcriptional levels of mir155 between children with bronchiolitis and control children.

Similar articles

Cited by

References

    1. Hall C.B., Weinberg G.A., Iwane M.K., Blumkin A.K., Edwards K.M., Staat M.A., Auinger P., Griffin M.R., Poehling K.A., Erdman D., et al. The burden of respiratory syncytial virus infection in young children. N. Engl. J. Med. 2009;360:588–598. doi: 10.1056/NEJMoa0804877. - DOI - PMC - PubMed
    1. Shi T., McAllister D.A., O’Brien K.L., Simoes E.A.F., Madhi S.A., Gessner B.D., Polack F.P., Balsells E., Acacio S., Aguayo C., et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: A systematic review and modelling study. Lancet. 2017;390:946–958. doi: 10.1016/S0140-6736(17)30938-8. - DOI - PMC - PubMed
    1. Shi T., Vennard S., Mahdy S., Nair H., RESCEU Investigators Risk Factors for Poor Outcome or Death in Young Children with Respiratory Syncytial Virus-Associated Acute Lower Respiratory Tract Infection: A Systematic Review and Meta-Analysis. J. Infect. Dis. 2022;226((Suppl. S1)):S10–S16. doi: 10.1093/infdis/jiaa751. - DOI - PubMed
    1. Kuhdari P., Brosio F., Malaventura C., Stefanati A., Orsi A., Icardi G., Gabutti G. Human respiratory syncytial virus and hospitalization in young children in Italy. Ital. J. Pediatr. 2018;44:50. doi: 10.1186/s13052-018-0492-y. - DOI - PMC - PubMed
    1. Rima B., Collins P., Easton A., Fouchier R., Kurath G., Lamb R.A., Lee B., Maisner A., Rota P., Wang L. Ictv Report Consortium. ICTV virus taxonomy profile: Pneumoviridae. J. Gen. Virol. 2017;98:2912–2913. doi: 10.1099/jgv.0.000959. - DOI - PMC - PubMed